Team:ULB-Brussels/human
From 2011.igem.org
(Difference between revisions)
(19 intermediate revisions not shown) | |||
Line 2: | Line 2: | ||
<head> | <head> | ||
<style> | <style> | ||
+ | |||
+ | #main h1{ | ||
+ | color: #690115; | ||
+ | font-weight: bolder; | ||
+ | } | ||
+ | |||
+ | #main h2{ | ||
+ | border-bottom-style: none; | ||
+ | text-decoration: underline; | ||
+ | font-weight: bolder; | ||
+ | |||
+ | } | ||
+ | <!-- | ||
+ | .vert { | ||
+ | color: #0F0; | ||
+ | } | ||
+ | .vert { | ||
+ | color: #0F0; | ||
+ | } | ||
+ | .vert { | ||
+ | color: #0F0; | ||
+ | } | ||
+ | .red { | ||
+ | color: #F00; | ||
+ | } | ||
+ | .black { | ||
+ | color: #000; | ||
+ | } | ||
+ | .red { | ||
+ | color: #F00; | ||
+ | } | ||
+ | --> | ||
+ | table | ||
+ | { | ||
+ | margin: auto; | ||
+ | width: 7000px; | ||
+ | padding: 20px; | ||
+ | } | ||
+ | |||
+ | td | ||
+ | { | ||
+ | padding-top: 10px; | ||
+ | padding-bottom: 10px; | ||
+ | } | ||
#menubar .left-menu noprint{ | #menubar .left-menu noprint{ | ||
Line 105: | Line 149: | ||
{ | { | ||
width:980px; | width:980px; | ||
- | height: | + | height:660px; |
margin: auto; | margin: auto; | ||
padding-left: 5px; | padding-left: 5px; | ||
Line 136: | Line 180: | ||
{ | { | ||
float: left; | float: left; | ||
- | padding: | + | padding-left: 10px; |
+ | padding-right: 10px; | ||
+ | |||
width:980px; | width:980px; | ||
- | height: 392px; | + | min-height: 392px; |
border: 2px inset #27303e; | border: 2px inset #27303e; | ||
text-align: justify; | text-align: justify; | ||
Line 530: | Line 576: | ||
background-color: #690115; | background-color: #690115; | ||
} | } | ||
+ | #sousm | ||
+ | { | ||
+ | clear:left; | ||
+ | position:relative; | ||
+ | top:112px; | ||
+ | margin-left: 225px; /*tu change ici pour le bouger horizontalement*/ | ||
+ | color:white; | ||
+ | widht: 900px; | ||
+ | } | ||
+ | #sousm a | ||
+ | { | ||
+ | position:relative; | ||
+ | color: white; | ||
+ | text-decoration: none; | ||
+ | text-align: center; | ||
+ | margin-left:20px; /*espace entre les lien*/ | ||
+ | display:block; /*Pour que le lien soit un vrai bloc*/ | ||
+ | float:left; /*Pour que les blocs soient alignés horizontalement (essayez de l'enlever pour voir)*/ | ||
+ | height:30px; /*La même hauteur que notre menu*/ | ||
+ | border:none; /*On enlève les bordures (enfin, on ne les met pas, même s'il n'y en avait pas)*/ | ||
+ | } | ||
</style> | </style> | ||
Line 535: | Line 602: | ||
</head> | </head> | ||
- | + | <div id="header"> <!-- Images de logo --> | |
<div id="menu"> | <div id="menu"> | ||
<a href="https://2011.igem.org/Team:ULB-Brussels">Home</a> | <a href="https://2011.igem.org/Team:ULB-Brussels">Home</a> | ||
<a href="https://2011.igem.org/Team:ULB-Brussels/project">Project</a> | <a href="https://2011.igem.org/Team:ULB-Brussels/project">Project</a> | ||
- | <a | + | <a href="https://2011.igem.org/Team:ULB-Brussels/modeling">Modelling</a> |
- | <a id="couleur"href="https://2011.igem.org/Team:ULB-Brussels/human">Human practice</a> | + | <a id="couleur" href="https://2011.igem.org/Team:ULB-Brussels/human">Human practice</a> |
- | <a href="https://2011.igem.org/Team:ULB-Brussels/ | + | <a href="https://2011.igem.org/Team:ULB-Brussels/Discussion">Discussion</a> |
<a href="https://2011.igem.org/Team:ULB-Brussels/parts">Parts</a> | <a href="https://2011.igem.org/Team:ULB-Brussels/parts">Parts</a> | ||
<a href="https://2011.igem.org/Team:ULB-Brussels/safety">Safety</a> | <a href="https://2011.igem.org/Team:ULB-Brussels/safety">Safety</a> | ||
<a href="https://2011.igem.org/Team:ULB-Brussels/team">Team</a> | <a href="https://2011.igem.org/Team:ULB-Brussels/team">Team</a> | ||
<a href="https://2011.igem.org/Team:ULB-Brussels/sponsors">Sponsors</a> | <a href="https://2011.igem.org/Team:ULB-Brussels/sponsors">Sponsors</a> | ||
+ | </div> | ||
+ | <div id="sousm"> | ||
+ | <a href="https://2011.igem.org/Team:ULB-Brussels/human">Introduction</a> | ||
+ | <a href="https://2011.igem.org/Team:ULB-Brussels/removing">Removing antibiotics resistance gene</a> | ||
+ | <a href="https://2011.igem.org/Team:ULB-Brussels/Questionnaire">Questionnaire</a> | ||
+ | <a href="https://2011.igem.org/Team:ULB-Brussels/Debate">Debate</a> | ||
+ | <a href="https://2011.igem.org/Team:ULB-Brussels/Bibliography">Bibliography</a> | ||
+ | |||
</div> | </div> | ||
Line 553: | Line 628: | ||
<div id="maintext"> | <div id="maintext"> | ||
<div id="hmaint"> | <div id="hmaint"> | ||
- | + | Introduction</div> | |
<div id="maint"> | <div id="maint"> | ||
- | + | <p>In this report, we present the bioethics part of the ULB-Brussels project. </p> | |
+ | <p>In the first section, we sum up our project from an ethical and theoretical point of view: </p> | ||
+ | <ul> | ||
+ | <li>what about the resistance to antibiotics? </li> | ||
+ | <li> what is clean biology? </li> | ||
+ | </ul> | ||
+ | <p>In the second section, we discuss the questionnaire given to a sample of the population. </p> | ||
+ | <ul> | ||
+ | <li>What was this questionnaire about? </li> | ||
+ | <li>What were our results? </li> | ||
+ | <li>How can we discuss them? </li> | ||
+ | </ul> | ||
+ | <p>And then in the third and last section, we analyze the debate we organized with the other Belgian team, the KULeuven Team, and draw conclusions about what we learned during this debate. </p> | ||
+ | |||
+ | <center><img src="http://www.philippetastet.com/contenu/en-version/bioethics.jpg"></center> | ||
</div> | </div> | ||
Line 564: | Line 653: | ||
<div id="bas"> | <div id="bas"> | ||
<div id="basi"> | <div id="basi"> | ||
- | iGEM ULB Brussels Team - <a href="mailto: | + | iGEM ULB Brussels Team - <a href="mailto:sgerard@ulb.ac.be">Contact us</a> |
</div> | </div> | ||
</div> | </div> | ||
</html> | </html> |
Latest revision as of 20:49, 21 September 2011
Introduction
In this report, we present the bioethics part of the ULB-Brussels project.
In the first section, we sum up our project from an ethical and theoretical point of view:
- what about the resistance to antibiotics?
- what is clean biology?
In the second section, we discuss the questionnaire given to a sample of the population.
- What was this questionnaire about?
- What were our results?
- How can we discuss them?
And then in the third and last section, we analyze the debate we organized with the other Belgian team, the KULeuven Team, and draw conclusions about what we learned during this debate.
![](http://www.philippetastet.com/contenu/en-version/bioethics.jpg)
iGEM ULB Brussels Team - Contact us